VERIGRAFT Advances First Potential Curative Treatment for CVI into Pivotal Phase II/III Trial
Pivotal Phase II/III clinical …
Pivotal Phase II/III clinical …
BANGKOK, Thailand, March 25, 2…
SUZHOU, China and STUTTGART, G…
BARCELONA, Spain, March 25, 20…
BENGALURU, India and MANILA, P…
First of its kind MoU in Singa…
TOKYO, March 25, 2026 /PRNewsw…
CHERRY VALLEY, Ark., March 25,…
Profit surges 72% to HK$97 mil…